CN101019853B - 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 - Google Patents
含有有效成分二均-γ-亚麻酸(DGLA)的组成物 Download PDFInfo
- Publication number
- CN101019853B CN101019853B CN 200610003112 CN200610003112A CN101019853B CN 101019853 B CN101019853 B CN 101019853B CN 200610003112 CN200610003112 CN 200610003112 CN 200610003112 A CN200610003112 A CN 200610003112A CN 101019853 B CN101019853 B CN 101019853B
- Authority
- CN
- China
- Prior art keywords
- dgla
- food
- skin
- atopic dermatitis
- mast cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005-036235 | 2005-02-14 | ||
| JP2005036235A JP5546087B2 (ja) | 2005-02-14 | 2005-02-14 | 皮膚疾患経口治療または予防剤 |
| JP2005036235 | 2005-02-14 | ||
| JP2005133271 | 2005-04-28 | ||
| JP2005133271A JP2006306813A (ja) | 2005-04-28 | 2005-04-28 | 肥満細胞増殖抑制剤 |
| JP2005-133271 | 2005-04-28 | ||
| JP2005133264A JP2006306812A (ja) | 2005-04-28 | 2005-04-28 | 好酸球浸潤抑制剤 |
| JP2005-133264 | 2005-04-28 | ||
| JP2005133264 | 2005-04-28 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100164426A Division CN102600174A (zh) | 2005-02-14 | 2006-02-14 | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101019853A CN101019853A (zh) | 2007-08-22 |
| CN101019853B true CN101019853B (zh) | 2013-05-15 |
Family
ID=36981996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610003112 Active CN101019853B (zh) | 2005-02-14 | 2006-02-14 | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5546087B2 (enExample) |
| CN (1) | CN101019853B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006306813A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 肥満細胞増殖抑制剤 |
| JP2006306812A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 好酸球浸潤抑制剤 |
| EP3581178B1 (en) | 2005-02-14 | 2023-08-30 | Suntory Holdings Limited | Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient |
| GB0907413D0 (en) * | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| WO2012153832A1 (ja) | 2011-05-12 | 2012-11-15 | 日本水産株式会社 | 炎症性疾患用皮膚外用組成物 |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| JP2014530841A (ja) * | 2011-10-19 | 2014-11-20 | ディグニティサイエンシスリミテッド | Dglaおよび/または15−hetreを含む医薬組成物、ならびにその使用方法 |
| US9855236B2 (en) | 2011-10-19 | 2018-01-02 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof |
| AU2014358145C1 (en) | 2013-12-04 | 2022-09-15 | Nippon Suisan Kaisha, Ltd. | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil |
| JP2017516823A (ja) | 2014-06-04 | 2017-06-22 | ディグニティ サイエンシス リミテッド | Dglaを含む薬学的組成物及びその使用 |
| JP2019501190A (ja) * | 2016-01-07 | 2019-01-17 | ディーエス バイオファーマ リミテッド | Dglaを含む薬学的組成物及びその使用 |
| CN109152759A (zh) * | 2016-06-01 | 2019-01-04 | 雀巢产品技术援助有限公司 | 用于预防变应性疾病的组合物 |
| CN110996937A (zh) * | 2017-05-19 | 2020-04-10 | Ds生物制药有限公司 | 包含dgla的药物组合物及其用途 |
| WO2020138480A1 (ja) * | 2018-12-28 | 2020-07-02 | 日本水産株式会社 | アラキドン酸含量が低減されたジホモ-γ-リノレン酸含有微生物油 |
| EP4039326A4 (en) * | 2019-10-01 | 2023-08-02 | Suntory Holdings Limited | COMPOSITION FOR IMPROVING INTESTINAL FUNCTION BY REGULATING THE EXPRESSION OF AQUAPORINE 3, AND THEIR USE |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| JP2023058456A (ja) * | 2021-10-13 | 2023-04-25 | 花王株式会社 | 抗アレルギー剤 |
| EP4417200A4 (en) * | 2021-10-13 | 2025-10-15 | Kao Corp | AGENT FOR THE PREVENTION, TREATMENT OR ALLEVIATION OF INFLAMMATORY SKIN DISEASE |
| JPWO2023181755A1 (enExample) * | 2022-03-22 | 2023-09-28 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47777B1 (en) * | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
| IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
| GB8806737D0 (en) * | 1988-03-22 | 1988-04-20 | Efamol Holdings | Therapeutic composition & method |
| JP2002047176A (ja) * | 2000-08-04 | 2002-02-12 | Idemitsu Technofine Co Ltd | IgE産生抑制剤 |
-
2005
- 2005-02-14 JP JP2005036235A patent/JP5546087B2/ja not_active Expired - Fee Related
-
2006
- 2006-02-14 CN CN 200610003112 patent/CN101019853B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006219454A (ja) | 2006-08-24 |
| CN101019853A (zh) | 2007-08-22 |
| JP5546087B2 (ja) | 2014-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10342773B2 (en) | Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient | |
| CN101019853B (zh) | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 | |
| Shahidi et al. | Omega-3 polyunsaturated fatty acids and their health benefits | |
| Raatz et al. | Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil | |
| US5059622A (en) | Method for reducing blood pressure levels in hypertensive persons | |
| US9445619B2 (en) | Compositions and methods for utilization of algal compounds | |
| CN101072509A (zh) | 炎症的治疗和预防 | |
| Salsinha et al. | Bioactive lipids: Chemistry, biochemistry, and biological properties | |
| US5834512A (en) | Prevention and improvement of allergy caused by leucotriene B 4 | |
| US20220143070A1 (en) | Composition for use in the prevention and/or treatment of dysbiosis | |
| Bhat | Functional Lipids as Nutraceuticals: A Review | |
| JP2006306813A (ja) | 肥満細胞増殖抑制剤 | |
| Kawabata et al. | Influences of stearidonic acid-enriched soybean oil on the blood and organ biochemical parameters in rats | |
| JP6203320B2 (ja) | 皮膚疾患経口治療または予防剤 | |
| JP2006306812A (ja) | 好酸球浸潤抑制剤 | |
| JP2012082226A (ja) | 皮膚疾患経口治療または予防剤 | |
| JP6462790B2 (ja) | 皮膚疾患経口治療または予防剤 | |
| JP6214474B2 (ja) | 皮膚疾患経口治療または予防剤 | |
| Wei et al. | Decreased n-6/n-3 polyunsaturated fatty acid ratio reduces chronic reflux esophagitis in rats | |
| JP7422160B2 (ja) | アクアポリン3の発現調節を介した腸機能改善用組成物及びその使用 | |
| Nath et al. | Role of Omega-3s in Functional Foods | |
| CN107970232A (zh) | 含n-3系不饱和脂肪酸的组合物、及n-3系不饱和脂肪酸在该组合物的制造中的应用 | |
| WO2024200778A1 (en) | Compositions for use in improving mobility | |
| Gaynor | Re: Generally Recognized as Safe (GRAS) Determination for GLA Safflower Oil (SONOVA®) in Conventional and Medical Foods Dear Dr. Gaynor: Arcadia Biosciences, Inc. has developed and intends to market gamma linolenic acid (GLA) safflower oil as conventional and medical food. This letter and attachments | |
| JP2020061956A (ja) | 血清中tmao低減用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SUNTORY HOLDINGS CO., LTD. Free format text: FORMER OWNER: SUNTORY LTD. Effective date: 20090703 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20090703 Address after: Osaka Japan Applicant after: Suntory Holdings Limited Address before: Osaka Japan Applicant before: Suntory Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |